Copyright
©The Author(s) 2018.
World J Clin Pediatr. Aug 30, 2018; 7(3): 75-82
Published online Aug 30, 2018. doi: 10.5409/wjcp.v7.i3.75
Published online Aug 30, 2018. doi: 10.5409/wjcp.v7.i3.75
Figure 1 The timeline of David’s life paralleled by the most significant advances in understanding and treating X-severe combined immunodeficiency.
SCID: Severe combined immunodeficiency; BMT: Bone marrow transplantation; HLA: Histocompatibility leukocyte antigen; EBV: Epstein-Barr virus; NASA: National Aeronautics and Space Administration.
- Citation: Tommasini A, Magnolato A, Bruno I. Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering. World J Clin Pediatr 2018; 7(3): 75-82
- URL: https://www.wjgnet.com/2219-2808/full/v7/i3/75.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v7.i3.75